483 Response GlaxoSmithKline Consumer Healthcare, LP Jan 2012

Alberto Viciedo FDA$119.00 - Available Now

FDA investigators audited the GlaxoSmithKline Consumer Healthcare, LP - Clifton, NJ, United States facility and issued inspectional observation (via FDA 483) on 09 Jan 2012.

Product details

  • Category:
  • Inspection end: 09 Jan 2012
  • Location: Clifton, United States
  • FEI: 2210777
Add To Cart